{"id":"https://openalex.org/W4308976785","doi":"https://doi.org/10.1093/neuonc/noac209.964","title":"RTID-04. CLINICAL POTENTIAL OF TARGETING TRANSFORMING GROWTH FACTOR BETA 2 WITH OT-101 FOR POST-RADIATION CONSOLIDATION IN DIFFUSE INTRINSIC PONTINE GLIOMA","display_name":"RTID-04. CLINICAL POTENTIAL OF TARGETING TRANSFORMING GROWTH FACTOR BETA 2 WITH OT-101 FOR POST-RADIATION CONSOLIDATION IN DIFFUSE INTRINSIC PONTINE GLIOMA","publication_year":2022,"publication_date":"2022-11-01","ids":{"openalex":"https://openalex.org/W4308976785","doi":"https://doi.org/10.1093/neuonc/noac209.964"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/noac209.964","doi":"https://doi.org/10.1093/neuonc/noac209.964","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noac209.964","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/24/Supplement_7/vii250/47021202/noac209.964.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/neuro-oncology/article-pdf/24/Supplement_7/vii250/47021202/noac209.964.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091381226","display_name":"Fatih Mehmet Uckun","orcid":"https://orcid.org/0000-0001-9334-183X","observed_orcids":["https://orcid.org/0000-0001-9334-183X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fatih Uckun","raw_affiliation_strings":["Oncotelic Therapeutics , Agoura Hills, CA , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncotelic Therapeutics , Agoura Hills, CA , USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059615305","display_name":"Vuong N. Trieu","orcid":"https://orcid.org/0000-0002-6675-0811","observed_orcids":["https://orcid.org/0000-0002-6675-0811"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vuong Trieu","raw_affiliation_strings":["Oncotelic Therapeutics , Agoura Hills, CA , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncotelic Therapeutics , Agoura Hills, CA , USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4612,"currency":"USD","value_usd":4612},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"24","issue":"Supplement_7","first_page":"vii250","last_page":"vii250"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diffuse-intrinsic-pontine-glioma","display_name":"diffuse intrinsic pontine glioma","score":0.9869999885559082},{"id":"https://openalex.org/keywords/transforming-growth-factor-beta2","display_name":"transforming growth factor-beta2","score":0.9100000262260437},{"id":"https://openalex.org/keywords/pediatric-brain-tumors","display_name":"pediatric brain tumors","score":0.6710000038146973},{"id":"https://openalex.org/keywords/rna-therapeutics","display_name":"RNA therapeutics","score":0.6610000133514404},{"id":"https://openalex.org/keywords/intrathecal-drug-delivery","display_name":"intrathecal drug delivery","score":0.8069999814033508},{"id":"https://openalex.org/keywords/immunosuppressive-tumor-microenvironment","display_name":"immunosuppressive tumor microenvironment","score":0.8849999904632568},{"id":"https://openalex.org/keywords/t-cell-unresponsiveness","display_name":"T cell hyporesponsiveness","score":0.8019999861717224},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7099999785423279},{"id":"https://openalex.org/keywords/convection-enhanced-delivery","display_name":"convection-enhanced delivery","score":0.7300000190734863},{"id":"https://openalex.org/keywords/glioma-cell-proliferation","display_name":"glioma cell proliferation","score":0.38999998569488525}],"concepts":[{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.8272431492805481},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7353855967521667},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5311609506607056},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4696245491504669},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3646182417869568},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32666802406311035},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32321614027023315}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/neuonc/noac209.964","doi":"https://doi.org/10.1093/neuonc/noac209.964","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noac209.964","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/24/Supplement_7/vii250/47021202/noac209.964.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9660909","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9660909","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/neuonc/noac209.964","doi":"https://doi.org/10.1093/neuonc/noac209.964","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noac209.964","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/24/Supplement_7/vii250/47021202/noac209.964.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4308976785.pdf","grobid_xml":"https://content.openalex.org/works/W4308976785.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2986172884","https://openalex.org/W4388588521","https://openalex.org/W2989877647","https://openalex.org/W4323665216","https://openalex.org/W97383484","https://openalex.org/W7124274524","https://openalex.org/W4294760697","https://openalex.org/W7162502690","https://openalex.org/W7127593341","https://openalex.org/W2954953528"],"abstract_inverted_index":{"Abstract":[0],"Diffuse":[1],"intrinsic":[2],"pontine":[3],"glioma":[4,55,82,99,129,169],"(DIPG)":[5],"in":[6,165,184,202,221,232,251,296],"children":[7,297],"has":[8,75],"a":[9,13,22,86,103,148,242],"dismal":[10],"prognosis":[11],"with":[12,235,254,298],"median":[14],"overall":[15,24],"survival":[16,25],"(OS)":[17],"of":[18,27,51,81,93,116,144,180,193,198,208,217,249,258,265,290],"10":[19],"months":[20],"and":[21,60,84,112,138,223,225,292],"2-year":[23],"rate":[26],"<":[28],"10%":[29],"after":[30,263],"standard":[31],"radiation":[32,266],"therapy.":[33],"Chemotherapy":[34],"does":[35],"offer":[36],"clinically":[37],"meaningful":[38],"benefits.":[39],"Therefore,":[40],"there":[41],"is":[42,102,274],"an":[43],"urgent":[44],"need":[45],"for":[46,49],"therapeutic":[47,106],"innovations":[48],"treatment":[50],"pediatric":[52,58,252],"DIPG.":[53,255,299],"High-grade":[54],"cells,":[56,130],"including":[57],"glioblastoma":[59],"DIPG":[61],"cells":[62,83],"have":[63],"been":[64,76],"shown":[65],"to":[66,89,108,188,239,276],"produce":[67],"transforming":[68],"growth":[69],"factor":[70],"beta":[71],"2":[72,150,287],"(TGFB2)":[73],"which":[74],"implicated":[77],"both":[78],"as":[79,85,134,136,268],"promoter":[80],"key":[87],"contributor":[88],"the":[90,94,110,124,140,185,190,199,206,279],"T-cell":[91],"hyporesponsiveness":[92],"tumor":[95,113],"microenvironment":[96],"(TME)":[97],"towards":[98],"cells.":[100],"OT-101":[101,122,155,220,250,259],"first-in-class":[104],"RNA":[105],"designed":[107,275],"abrogate":[109],"immunosuppressive":[111],"promoting":[114],"actions":[115],"TGF-B2.":[117],"At":[118],"low":[119],"micromolar":[120],"concentrations,":[121],"reduces":[123],"TGFB2":[125],"secretion":[126],"by":[127,212,227],"human":[128],"blocks":[131],"their":[132],"proliferation":[133],"well":[135],"migration,":[137],"restores":[139],"anti-glioma":[141],"cytolytic":[142],"function":[143],"patient-derived":[145],"T-cells.":[146],"In":[147],"Phase":[149,246,286],"clinical":[151],"study,":[152],"intracerebrally":[153],"applied":[154],"administered":[156,262],"via":[157],"convection-enhanced":[158],"delivery":[159],"showed":[160],"promising":[161],"single":[162,229],"agent":[163,230],"activity":[164,231],"Recurrent/Refractory":[166],"(R/R)":[167],"high-grade":[168],"(HGG)":[170],"(Uckun":[171],"et":[172],"al.,":[173],"Cancers.":[174],"2019":[175],"28;11(12):1892).":[176],"The":[177,272],"intrathecal":[178,269],"administration":[179],"antineoplastic":[181,200],"drugs":[182],"directly":[183],"CSF":[186],"allows":[187],"bypass":[189],"selective":[191],"filter":[192],"BBB,":[194],"achieving":[195],"significant":[196],"concentrations":[197],"agents":[201],"CSF,":[203],"while":[204],"reducing":[205],"likelihood":[207],"systemic":[209],"toxicity.":[210],"Informed":[211],"favorable":[213],"safety":[214],"pharmacology":[215],"studies":[216],"intrathecally":[218],"delivered":[219],"rabbits":[222],"primates":[224],"encouraged":[226],"its":[228,294],"adult":[233],"patients":[234,253],"HGG,":[236],"we":[237],"decided":[238],"embark":[240],"upon":[241],"multi-center,":[243],"two-part,":[244],"randomized":[245],"1-2":[247],"study":[248,273],"Multiple":[256],"doses":[257],"will":[260],"be":[261],"completion":[264],"therapy":[267],"bolus":[270],"injections.":[271],"determine:":[277],"1)":[278],"maximum":[280],"tolerated":[281],"dose":[282,288],"(MTD)":[283],"or":[284],"recommended":[285],"(RP2D)":[289],"OT-101,":[291],"2)":[293],"efficacy":[295]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-11-20T00:00:00"}